Compugen (CGEN) Assets Average (2009 - 2026)
Compugen (CGEN) posted quarterly Assets Average of $151.2 million for Q1 2026, up 31.24% year-over-year from $115.2 million in Q1 2025, and up 18.87% on a QoQ basis from $127.2 million in Q4 2025.
Compugen (CGEN) Assets Average (2009 - 2026) Analysis & Trends
Compugen has reported Assets Average for 18 years, with the latest figure at $151.2 million in Q1 2026.
- Assets Average for Q1 2026 came in at $151.2 million, up 31.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $151.2 million (up 31.24% YoY), and the FY2025 annual result was $135.8 million, up 14.91% from the prior year.
- Assets Average advanced to $151.2 million in Q1 2026, from $127.2 million in the prior quarter.
- Over five years, Assets Average peaked at $151.2 million in Q1 2026 and troughed at $72.3 million in Q3 2023.
- A 5-year average of $109.0 million and a median of $111.9 million in 2024 frame the typical range for Assets Average.
- The widest annual swing landed in 2023, when Assets Average plunged 31.01%; it then surged 61.53% in 2024.
- A 5-year view of Assets Average shows it stood at $96.8 million in 2022, then declined by 2.38% to $94.5 million in 2023, then grew by 26.23% to $119.3 million in 2024, then climbed by 6.67% to $127.2 million in 2025, then climbed by 18.87% to $151.2 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $151.2 million in Q1 2026, $127.2 million in Q4 2025, and $102.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 3.29 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 8.86 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 16.08 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.34 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.09 Bn |
| 10 | Compugen | 227.88 Mn | 136.13 Mn | 352,000.00 | 151.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151.22 Mn |
| Dec 31, 2025 | 127.21 Mn |
| Sep 30, 2025 | 102.19 Mn |
| Jun 30, 2025 | 110.98 Mn |
| Mar 31, 2025 | 115.22 Mn |
| Dec 31, 2024 | 119.26 Mn |
| Sep 30, 2024 | 116.84 Mn |
| Jun 30, 2024 | 111.93 Mn |
| Mar 31, 2024 | 117.52 Mn |
| Dec 31, 2023 | 94.47 Mn |
| Sep 30, 2023 | 72.33 Mn |
| Jun 30, 2023 | 80.69 Mn |
| Mar 31, 2023 | 89.25 Mn |
| Dec 31, 2022 | 96.77 Mn |
| Sep 30, 2022 | 104.84 Mn |
| Jun 30, 2022 | 115.62 Mn |
| Mar 31, 2022 | 126.55 Mn |
| Dec 31, 2021 | 126.73 Mn |
| Sep 30, 2021 | 122.06 Mn |
| Jun 30, 2021 | 126.40 Mn |